Twenty years after the National Institutes of Health (NIH) Revitalization Act established a mandate for more appropriate representation of minority groups in NIH-funded research, the degree of focus on minorities in US clinical trials sponsored by the National Cancer Institute (NCI) remains “woefully inadequate”, a new review has found.
Read MoreThe Global Health Innovative Technology (GHIT) Fund, a pioneering initiative involving the government of Japan, the Bill & Melinda Gates Foundation and five Japanese pharmaceutical companies, has announced funding of more than US$12 million to accelerate development of novel tools and drugs to combat tuberculosis and other neglected diseases.
Read MorePAREXEL International has further boosted the global capacity of its Clinical Logistics Services (CLS) network with a new, state-of-the-art distribution centre in Singapore and expanded US facilities in Billerica, Massachusetts.
Read MoreCharles River Laboratories (CRL), the US-based provider of drug discovery and development services, has filled out its portfolio with upstream in vitro capabilities by agreeing to acquire the contract-research services division of Galapagos NV.
Read MoreUS industry association the Pharmaceutical Research and Manufacturers of America (PhRMA) has stepped up its efforts to encourage diversity in clinical trials by launching a national awareness campaign with existing partner the National Minority Quality Forum.
Read More
